Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04253054
Other study ID # CMCS-Beijing 2020
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date September 7, 2020
Est. completion date March 2021

Study information

Verified date December 2020
Source Beijing Institute of Heart, Lung and Blood Vessel Diseases
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Chinese Multi-provincial Cohort Study (CMCS)-Beijing project is a sub-study in CMCS participants from Beijing, which intended to investigate the progression and determinants of atherosclerosis and aging related health problems through repeat examinations. Exam 0 to Exam 3 have been conducted during 1992 to 2012. Exam 4 is scheduled in 2020.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 3000
Est. completion date March 2021
Est. primary completion date March 2021
Accepts healthy volunteers No
Gender All
Age group 60 Years to 100 Years
Eligibility Inclusion Criteria: - Participants from CMCS-Beijing - sign the informed consent Exclusion Criteria: - participanting in clinical trials

Study Design


Intervention

Other:
Cardiovascular risk factors
Different level of cardiovascular risk factors, such as aging, hypertension, diabetes, dyslipidemia, smoke, alcohol drink, obesity and et al, associated with genetics, environments and lifestyles
Aging related health problems
Aging related health problems

Locations

Country Name City State
China Beijing Sijiqing Hospital, Beijing Beijing
China Peking University Hospital, Beijing Beijing
China Peking University Shougang Hospital Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Institute of Heart, Lung and Blood Vessel Diseases

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary All fatal and nonfatal acute coronary and stroke events Acute coronary heart disease events included acute myocardial infarction, sudden death, and other coronary deaths. Acute stroke events included subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral infarction. From date of enrollment until the date of first documented event or date of cardiovascular death, whichever came first, assessed at least 5 years
Secondary New-onset of coronary events Acute coronary heart disease events included acute myocardial infarction, sudden death, and other coronary deaths. From date of enrollment until the date of first documented event or date of CHD death, whichever came first, assessed at least 5 years
Secondary New-onset of stroke Acute stroke events included subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral infarction. From date of enrollment until the date of first documented event or date of stroke death, whichever came first, assessed at least 5 years
Secondary Total death All cause death From date of enrollment until date of death from all cause, assessed at least 5 years
Secondary Cognitive dysfunction Cognitive dysfunction From date of enrollment until date of first documented event, assessed at least 5 years
Secondary Olfactory Disorders Olfactory Disorders From date of enrollment until date of first documented event, assessed at least 5 years
Secondary Valvular disease Valvular disease From date of enrollment until the date of first documented event or date of valvular disease death, whichever came first, assessed at least 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04098172 - Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR N/A